About us
Pricing
Contact
Subscribe
Journals
Articles
Research Areas
Publishers
Trends
World Map
Compare
Site Map
T
Tudor–Eliade Ciuleanu
Institute of Oncology Prof. Dr. Ion Chiricuta
ORCID https://orcid.org/0000-0003-0958-5597
h-index
—
Publications
—
Citations
—
i10-index
—
Impact (2-yr)
—
Top Publications
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
The Lancet Oncology
2014
1,480 citations
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial
The Lancet Oncology
2021
1,333 citations
Tudor–Eliade Ciuleanu · Scinovex
